Novartis

Member of UN Global Compact

Headquarters in Switzerland

Novartis website

🔎 Run a search for “Novartis”

Get RSS feed of these results

All stories

Item
15 October 2014

USA: Video report on role of pharmaceutical & insurance companies in high price of cancer drugs

Author: CBS 60 Minutes (USA)

"The Cost of Cancer Drugs", 5 Oct 2014...

Read more

Article
8 October 2014

Modi must resist U.S. pressure on drug patents - MSF

Author: Nita Bhalla, Reuters

Prime Minister Narendra Modi must not give in to U.S. pressure to change intellectual property laws which allow India to produce generic medicines poor people can afford, the medical charity Doctors Without Borders (MSF) said…MSF said U.S. officials...

Read more

Article
8 October 2014

Why did Modi agree to give away India’s patent sovereignty to Americans?

Author: G Pramod Kumar, Firstpost

Prime Minister Narendra Modi’s US visit was dubbed as a great bilateral victory for India… The sector in question is Intellectual Property Rights (IPR)… The leaders…talk about a high level bilateral working group on intellectual property... most...

Read more

Article
12 August 2014

Kenya: Novartis' Healthy Family Initiative aims to improve access to healthcare through training health educators & engaging communities

Author: Karen Newman, Guardian (UK)

"Novartis aims to improve healthcare access in developing nations", 7 August 2014...

Read more

Article
8 August 2014

Kenya: Novartis’ Familia Nawiri initiative aims to help address healthcare challenges through education

Author: Karen Newman, UNDP, in Guardian Sustainable Business

"Novartis aims to improve healthcare access in developing nations", 7 Aug 2014...

Read more

Article
25 June 2014

Novartis convenes 13th annual malaria expert panel with a focus on access to quality antimalarials across Africa

Author: African Press Organization

There is a need for quality-assured antimalarial treatments in both the private and public sectors…Half of patients in Africa buy antimalarials from the private sector…where wide availability of sub-standard treatment is putting patients’ lives at...

Read more

Article
1 May 2014

[PDF] Evidence of Corporate Disclosure relevant to the UN Guiding Principles on Business and Human Rights

Author: Shift

This research was conducted to inform understanding of how companies currently report on their human rights performance, and how this maps against the UN Guiding Principles on Business & Human Rights. The research reviewed corporate disclosure of...

Read more

Lawsuit
26 March 2014

Novartis lawsuit (re India patent law & access to medicine)(new)

Author: Business & Human Rights Resource Centre

Worldwide, Novartis is the main producer of Glivec, a drug used for treating blood cancer.  The company has sought a patent that would give it the exclusive right to produce Glivec, stopping production by the generic drugs industry in India.  ...

Read more

Story
25 March 2014

Novartis lawsuit (re India patent law & access to medicine)

Worldwide, Novartis is the main producer of Glivec, a drug used for treating blood cancer.  The company has sought a patent that would give it the exclusive right to produce Glivec, stopping production by the generic drugs industry in India.  ...

See full story

Article
19 February 2014

Allegations of pharmaceutical group's planned opposition to So. Africa reforms to increase access to medicines - company responses/non-responses

Author: Business & Human Rights Resource Centre

In January 2014, the Innovative Pharmaceutical Association of South Africa (IPASA) was accused of planning and funding an advocacy campaign on behalf of its member companies. The campaign allegedly sought to oppose South Africa’s efforts to introduce...

Read more